1. Home
  2. RGEN vs LEA Comparison

RGEN vs LEA Comparison

Compare RGEN & LEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$177.23

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Logo Lear Corporation

LEA

Lear Corporation

N/A

Current Price

$121.37

Market Cap

8.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
RGEN
LEA
Founded
1981
1917
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
8.3B
IPO Year
1995
1994

Fundamental Metrics

Financial Performance
Metric
RGEN
LEA
Price
$177.23
$121.37
Analyst Decision
Buy
Buy
Analyst Count
22
16
Target Price
★ $189.70
$150.86
AVG Volume (30 Days)
★ 880.1K
523.2K
Earning Date
10-27-2026
10-30-2026
Dividend Yield
N/A
★ 2.61%
EPS Growth
★ 286.96
N/A
EPS
0.24
★ 7.13
Revenue
$141,236,000.00
★ $23,259,100,000.00
Revenue This Year
$12.04
$2.38
Revenue Next Year
$17.80
$1.29
P/E Ratio
$805.46
★ $16.80
Revenue Growth
★ 35.10
N/A
52 Week Low
$100.99
$96.04
52 Week High
$198.87
$150.33

Technical Indicators

Market Signals
Indicator
RGEN
LEA
Relative Strength Index (RSI) 63.35 38.82
Support Level $159.22 $116.08
Resistance Level N/A $119.25
Average True Range (ATR) 6.58 3.08
MACD 0.98 -0.49
Stochastic Oscillator 75.63 2.24

Price Performance

Historical Comparison
RGEN
LEA

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About LEA Lear Corporation

Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.

Share on Social Networks: